COSMOS Pharmaceutical Corp.

  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: JP3298400007
JPY
7,556.00
-172 (-2.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Feb'25
Nov'24
Aug'24
May'24
Feb'24
Nov'23
Aug'23
Net Sales
2,46,332.00
2,44,095.00
2,61,841.00
2,49,678.00
2,38,881.00
2,34,777.00
2,41,653.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,46,332.00
2,44,095.00
2,61,841.00
2,49,678.00
2,38,881.00
2,34,777.00
2,41,653.00
Raw Material Cost
1,93,198.00
1,92,584.00
2,07,278.00
2,01,036.00
1,92,149.00
1,88,858.00
1,94,640.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
48.00
48.00
49.00
46.00
18.00
17.00
18.00
Selling and Distribution Expenses
41,850.00
42,748.00
42,982.00
40,879.00
38,831.00
39,072.00
38,022.00
Other Expenses
-4.80
-4.80
-4.90
-4.60
-1.80
-1.70
-1.80
Total Expenditure (Excl Depreciation)
2,35,048.00
2,35,332.00
2,50,260.00
2,41,915.00
2,30,980.00
2,27,930.00
2,32,662.00
Operating Profit (PBDIT) excl Other Income
11284
8763
11581
7763
7901
6847
8991
Other Income
655.00
645.00
608.00
532.00
472.00
797.00
696.00
Operating Profit (PBDIT)
17,569.00
14,808.00
17,375.00
13,718.00
13,466.00
12,466.00
14,273.00
Interest
48.00
48.00
49.00
46.00
18.00
17.00
18.00
Exceptional Items
-148.00
16.00
-71.00
-471.00
374.00
-50.00
-32.00
Gross Profit (PBDT)
53,134.00
51,511.00
54,563.00
48,642.00
46,732.00
45,919.00
47,013.00
Depreciation
5,630.00
5,400.00
5,186.00
5,423.00
5,093.00
4,822.00
4,586.00
Profit Before Tax
11,743.00
9,377.00
12,066.00
7,777.00
8,729.00
7,577.00
9,636.00
Tax
3,828.00
3,092.00
3,922.00
681.00
2,959.00
2,497.00
3,128.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
7,915.00
6,285.00
8,143.00
7,097.00
5,770.00
5,079.00
6,508.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
7,915.00
6,285.00
8,143.00
7,097.00
5,770.00
5,079.00
6,508.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
7,915.00
6,285.00
8,143.00
7,097.00
5,770.00
5,079.00
6,508.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,48,822.00
2,43,486.00
2,37,204.00
2,31,442.00
2,24,281.00
2,20,889.00
2,15,302.00
Earnings per share (EPS)
99.86
79.3
102.74
89.54
145.6
64.1
82.17
Diluted Earnings per share
99.86
79.3
102.74
89.54
145.6
64.1
82.17
Operating Profit Margin (Excl OI)
4.58%
3.59%
4.42%
3.11%
3.31%
2.92%
3.72%
Gross Profit Margin
7.05%
6.05%
6.59%
5.29%
5.79%
5.28%
5.89%
PAT Margin
3.21%
2.57%
3.11%
2.84%
2.42%
2.16%
2.69%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Feb 2025 is 0.92% vs -6.78% in Nov 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Feb 2025 is 25.93% vs -22.82% in Nov 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Feb 2025 is 19.42% vs -15.53% in Nov 2024

stock-summary

Interest

QoQ Growth in quarter ended Feb 2025 is 0.00% vs -2.04% in Nov 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Feb 2025 has improved from Nov 2024

Compare Quarterly Results Of COSMOS Pharmaceutical Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
2,46,332.00
3,33,089.00
-86,757.00
-26.05%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,46,332.00
3,33,089.00
-86,757.00
-26.05%
Raw Material Cost
1,93,198.00
2,28,757.00
-35,559.00
-15.54%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
48.00
205.00
-157.00
-76.59%
Selling and Distribution Expenses
41,850.00
90,778.00
-48,928.00
-53.90%
Other Expenses
-4.80
-20.50
15.70
76.59%
Total Expenditure (Excl Depreciation)
2,35,048.00
3,19,535.00
-84,487.00
-26.44%
Operating Profit (PBDIT) excl Other Income
11,284.00
13,554.00
-2,270.00
-16.75%
Other Income
655.00
1,105.00
-450.00
-40.72%
Operating Profit (PBDIT)
17,569.00
22,349.00
-4,780.00
-21.39%
Interest
48.00
205.00
-157.00
-76.59%
Exceptional Items
-148.00
-13,731.00
13,583.00
98.92%
Gross Profit (PBDT)
53,134.00
1,04,332.00
-51,198.00
-49.07%
Depreciation
5,630.00
7,690.00
-2,060.00
-26.79%
Profit Before Tax
11,743.00
722.00
11,021.00
1,526.45%
Tax
3,828.00
738.00
3,090.00
418.70%
Provisions and contingencies
0
0
0.00
Profit After Tax
7,915.00
179.00
7,736.00
4,321.79%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
7,915.00
179.00
7,736.00
4,321.79%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-196.00
196.00
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
7,915.00
-17.00
7,932.00
46,658.82%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,48,822.00
2,48,615.00
207.00
0.08%
Earnings per share (EPS)
99.86
0.82
99.04
12,078.05%
Diluted Earnings per share
99.86
0.82
99.04
12,078.05%
Operating Profit Margin (Excl OI)
4.58%
4.07%
0.00
0.51%
Gross Profit Margin
7.05%
2.53%
0.00
4.52%
PAT Margin
3.21%
0.05%
0.00
3.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 24,633.20 Million
in Feb 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Feb 2025 is 0.92% vs -6.78% in Nov 2024

stock-summary

YoY Growth in quarter ended Feb 2025 is 3.12% vs 18.09% in Feb 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 791.50 Million
in Feb 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Feb 2025 is 25.93% vs -22.82% in Nov 2024

stock-summary

YoY Growth in quarter ended Feb 2025 is 37.18% vs 15.77% in Feb 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,691.40 Million
in Feb 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Feb 2025 is 19.42% vs -15.53% in Nov 2024

stock-summary

YoY Growth in quarter ended Feb 2025 is 30.17% vs 15.94% in Feb 2024

Quarterly - Interest
Interest 4.80 Million
in Feb 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Feb 2025 is 0.00% vs -2.04% in Nov 2024

stock-summary

YoY Growth in quarter ended Feb 2025 is 166.67% vs 63.64% in Feb 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.58%
in Feb 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Feb 2025 has improved from Nov 2024

stock-summary

YoY Growth in quarter ended Feb 2025 has improved from Feb 2024